CKD-828 Telmisartan Non-Responder Trial

NCT01426100 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: CKD-828 40/2.5mg
DRUG: CKD-828 40/5mg
DRUG: Telmisartan 80mg

Sponsor

Chong Kun Dang Pharmaceutical